Radboud University Medical Center
π³π±Netherlands
- Country
- π³π±Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
OPTIMA FORMA Phase 3
Not Applicable
Completed
- Conditions
- Chronic Conditions, MultipleChronic Condition
- Interventions
- Other: Usual careBehavioral: Person-centred integrated care intervention
- First Posted Date
- 2022-08-10
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 842
- Registration Number
- NCT05495230
- Locations
- π³π±
Radboudumc, Nijmegen, Netherlands
Relative Bioavailability Study to Investigate a Potential Interaction Between DTG DT and F/TAF TOS.
Phase 1
Completed
- Conditions
- Hiv
- Interventions
- Drug: DTG DT (6 x 5 mg)Drug: F/TAF TOS (3 x 60/7.5 mg)
- First Posted Date
- 2022-08-05
- Last Posted Date
- 2023-12-06
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 16
- Registration Number
- NCT05489406
- Locations
- π³π±
RTCCS Radboudumc, Nijmegen, Netherlands
Optical Diagnosis Versus Laser Measurement of Polyps' Size During Colonoscopy and Implications for Surveillance
Not Applicable
- Conditions
- Colorectal Polyp
- Interventions
- Device: AccuMeasure
- First Posted Date
- 2022-08-05
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 138
- Registration Number
- NCT05489380
- Locations
- πΊπΈ
Indiana University Hospital, Indianapolis, Indiana, United States
πΊπΈNYU Langone Health, New York, New York, United States
π³π±Radboud university medical center, Nijmegen, Gelderland, Netherlands
Artificial Intelligence and Radiologists at Prostate Cancer Detection in MRI: The PI-CAI Challenge
Completed
- Conditions
- Prostate Cancer
- Interventions
- Diagnostic Test: Histopathology and Magnetic Resonance Imaging with Follow-UpDiagnostic Test: Histopathology and Magnetic Resonance Imaging
- First Posted Date
- 2022-08-05
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 10207
- Registration Number
- NCT05489341
- Locations
- π³π±
RadboudUMC, Nijmegen, Gelderland, Netherlands
LSD to Improve Cluster Headache Impact Trial
- First Posted Date
- 2022-07-28
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 65
- Registration Number
- NCT05477459
- Locations
- π³π±
Leiden University Medical Center (LUMC), Leiden, Netherlands
π³π±Canisius-Wilhelmina Ziekenhuis (CWZ), Nijmegen, Netherlands
Soft Mist Spray Device for Airway Anaesthesia During Awake Videolaryngoscopy
Not Applicable
Completed
- Conditions
- Anesthesia, LocalAirway
- Interventions
- Device: Trachospray for awake videolaryngoscopy
- First Posted Date
- 2022-07-28
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT05478122
- Locations
- π³π±
Radboudumc, Nijmegen, Netherlands
Incidence, Risk Factor, Treatment and Overall Survival of Locoregionally Recurrent Colon Cancer
Completed
- Conditions
- Neoplasm Recurrence, LocalColonic Neoplasms
- First Posted Date
- 2022-07-26
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 3554
- Registration Number
- NCT05475288
Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer
Completed
- Conditions
- Neoplasm Recurrence, LocalRectal Neoplasms
- First Posted Date
- 2022-07-26
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 1431
- Registration Number
- NCT05475301
Pre-hospital Rule-out of Acute Coronary Syndrome
Not Applicable
- Conditions
- Acute Coronary Syndrome
- Interventions
- Diagnostic Test: Pre-hospital rule-out strategy
- First Posted Date
- 2022-07-20
- Last Posted Date
- 2022-07-25
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 866
- Registration Number
- NCT05466591
- Locations
- π³π±
RadboudUMC, Nijmegen, Netherlands
Dutch Intracerebral Hemorrhage Surgery Trial
Not Applicable
Recruiting
- Conditions
- Intracerebral HemorrhageMinimally Invasive Surgical ProceduresEndoscopic Surgical Procedures
- Interventions
- Device: Minimally invasive endoscopy-guided surgery
- First Posted Date
- 2022-07-15
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 600
- Registration Number
- NCT05460793
- Locations
- π³π±
Amsterdam University Medical Center, Amsterdam, Netherlands
π³π±Medisch Spectrum Twente, Enschede, Netherlands
π³π±University Medical Center Groningen, Groningen, Netherlands
Β© Copyright 2025. All Rights Reserved by MedPath